✦ LIBER ✦

Progress in chemotherapy of non-small cell lung cancer

✍ Scribed by Sculier, Jean-Paul; Klastersky, Jean

Book ID: 121948467
Publisher: Elsevier Science
Year: 1984
Weight: 488 KB
Volume: 20
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(84)90049-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose and schedule finding study of gem

A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy

✍ Biesma, B.; Smit, E.F.; Postmus, P.E. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Randomized Phase II Trial of Erlotinib W

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

✍ Witta, S. E.; Jotte, R. M.; Konduri, K.; Neubauer, M. A.; Spira, A. I.; Ruxer, R 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 917 KB

High response of second-line chemotherap

High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy

✍ Oscar Arrieta; Cynthia Villarreal-Garza; Digna Pachuca; Rosa M. Michel Ortega; L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 179 KB

Individual-level data on the relationshi

Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy

✍ Hisao Imai,Keita Mori,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 213 KB

Follow-up with 18FDG-PET–CT after radica

Follow-up with 18FDG-PET–CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study

✍ Judith van Loon; Janneke Grutters; Rinus Wanders; Liesbeth Boersma; Michel Oelle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 171 KB

9147 Bevacizumab and erlotinib as first-

9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB